Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, June 24 at 2:00 PM EDT

Register Free →

Doxycycline Hyclate Contract Award SPE2D2-25-D-0015

Awarded
SPE2D2-25-D-0015Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The contract awarded under solicitation number SPE2D2-25-D-0015 pertains to the supply of Doxycycline Hyclate, a pharmaceutical product, and is managed by the DLA Troop Support within the Department of Defense. The contract was posted on July 2, 2025, and is associated with the NAICS code 325412, which covers pharmaceutical manufacturing. The performance of this contract is designated to take place in Laurelton, New York, with the Department of Defense's main office located in Philadelphia, Pennsylvania. Key points of contact include Courtney Hunter-Stangler and Catherine Gilbert, both reachable via email and phone for inquiries. The contract's scope and size are not explicitly specified, but it is part of a broader effort to procure medical supplies for military and defense purposes. Additional details and updates can be accessed through the provided link on SAM.gov.

General Info

DoD awarded PURACAP Laboratories $6.4M contract for Doxycycline supply through 2030.

Agency

Department Of Defense → DLA Troop Support

Contract Value

$6,425,267.05

NAICS

325412 - Pharmaceutical Preparation Manufacturing View NAICS

Place of Performance

Laurelton, NY, 11413, USA

Set-Aside

NONE

Awardee

PURACAP LABORATORIES LLCView Profile

Award Issued Date

Documents

(2)

SF30_SPE2D225D0015P00001.PDF

PDF

SPE2D2-25-D-0015+-+Doxycycline+Hyclate+-+Bilaterally+Signed+Award.pdf

PDF

AI Contract Breakdown

Uniform Contract Format

What is UCF?

Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.

Timeline

PhaseAwarded
Awarded

Contract was awarded

Posted

award-notice

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → DLA Troop Support
Contacts2 people available
OfficePHILADELPHIA, PA, 19111, USA
Organization / Agency
Department Of Defense → DLA Troop Support
Office AddressPHILADELPHIA, PA, 19111, USA

Full Description

Show more

1. Option #1 is hereby executed for the period July 2, 2026 through July 1, 2027.



2. All other terms and conditions remain unchanged.

Similar Contracts

NAICS: 325412
New
Federal
6505--Dutasteride CapsulesThe Department of Veterans Affairs National Acquisition Center plans to issue a Request for Proposal (RFP 36E79726R0029) for the procurement of Dutasteride Capsules to serve multiple federal agencies, including the VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. This unrestricted contract aims to secure a reliable supply source for Dutasteride 0.5MG capsules in both 30-count and 90-count bottles, with annual estimated usage of approximately 3,912 and 25,502 bottles respectively. The contract will be awarded to a single responsible offeror who can provide an uninterrupted supply and will have a one-year base period followed by four one-year option periods. Distribution will be managed through the VA and DoD Pharmaceutical Prime Vendor Programs. Offerors must supply the drug under the exact name on the label, with a unique National Drug Code (NDC) exclusive to the offeror. The contractor’s label must be the sole label on the product, with VA labels designed to adhere securely on top without obscuring important information such as barcodes, expiration dates, and lot numbers. Packaging requirements include safety caps that meet specific design criteria with a minimum bottle volume of 120cc and cylindrical shape to accommodate appropriate labeling sizes. The solicitation will be released in a commercial item format in accordance with FAR Part 12 around June 22, 2026, with proposals due by July 7, 2026. Interested parties should monitor SAM.gov for updates and submit offers electronically; efforts to obtain paper copies will not be accommodated. The contract specialist and primary point of contact for this procurement is Richard Mahario.
Nac Pharmaceuticals (36E797)

POSTED

1 day ago

DEADLINE

in 21 days
View Details